Ekowati Rahajeng

Prof. Ekowati Rahajeng

Centre of Public Health Researh and Nutrition, National Research and Innovation Agency, Jakarta, Indonesia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2019 in Biomedicines
Verified
Journal Article
Open access
PDF file
RLRahma Larasati
Rahma Larasati
DHDante Saksono Harbuwono
Dante Saksono Harbuwono
EREkowati Rahajeng
Ekowati Rahajeng
SPSaraswati Pradipta
Saraswati Pradipta
HNHanny Siti Nuraeni
Hanny Siti Nuraeni
HWHeri Wibowo
Heri Wibowo
Type 2 Diabetes Mellitus (T2DM) is a very serious global problem. In Indonesia, this disease attacks at the most productive age; consequently, it can reduce economic status and life expectancy. The pathogenesis of T2DM is very closely related to inflammation and macrophage accumulation. However, no anti-inflammatory agent has been proven to play a role in the management of T2DM. Butyrate is a short chain fatty acid produced from resistant starch fermentation in the intestinal lumen. It is able to bind to GPR41 and GPR43 receptors on monocytes, so that it can change the pattern of cytokine expression, activation, migration and cell differentiation. Hence, it is interesting to examine the anti-inflammation effect of butyrate and the effect on monocyte migration. A total of 37 subjects were examined in this study. They were divided into two groups, with and without butyrate treatment. We analyzed two pro-inflammatory cytokines (Tumor Necrosis Factor TNF-α and Interleukin IL-6) and one anti-inflammatory cytokine, IL 10. Monocytes were isolated in type 1 collagen gel for migration testing using the µ-slide chemotaxis IBIDI. Image analysis used ImageJ and Chemotaxis tool software. There was a significant difference in the TNFα/IL 10 ratio between healthy groups and T2DM. Butyrate also appears to suppress TNFα cytokine production and increase IL10 production. It also decreases the accumulation distance of monocyte migration in T2DM.

23 September 2020 in Jurnal Ekologi Kesehatan
Verified
Journal Article
Open access
PDF file
EREkowati Rahajeng
Ekowati Rahajeng
ENEnung Nurhotimah
Enung Nurhotimah
Posbindu PTM is one of NCD risk factor prevention and control programs in Indonesia. About 50.6% of villages already carry out Posbindu PTM, but the prevalence of PTM risk factors remains high. This article aims to inform the results of the evaluation of Posbindu PTM implementation in residential environment, including benefits, utilization, constraints and implementation opportunities. Evaluation is carried out through a systemic review of articles related Posbindu PTM implementations published online in 2015-2020. Articles searched through google scholar search engine, Garuda portal, and Pubmed/PMC with keywords: Posbindu PTM implementation, utilization of Posbindu PTM, constraints and opportunities. As a selection criterion is the article is the result of research or evaluation of the implementation of Posbindu PTM and its utilization, and the article can be accessed in full text. Publications totaled 44 articles, and 19 articles met the criteria. Posbindu PTM activities generally have not been implemented regularly and comprehensively. The problem with the implementation of Posbindu PTM is that the officer is not precise in setting targets, lack of operational funds, and limited ability of cadres. Improving the benefits of Posbindu PTM requires the coaching of health workers, strengthening cadre competencies in counseling/education, and strengthening regulation in the region. Keywords: Posbindu PTM, implementation, benefits, obstacles, opportunity ABSTRAK Posbindu PTM merupakan salah satu program pencegahan dan pengendalian faktor risiko PTM di Indonesia. Sekitar 50,6% desa sudah melaksanakan Posbindu PTM, namun prevalensi faktor risiko PTM tetap tinggi. Artikel ini bertujuan menginformasikan hasil evaluasi pelaksanaan Posbindu PTM di lingkungan tempat tinggal, meliputi manfaat, pemanfaatan, kendala dan peluang pelaksanaanya. Evaluasi dilakukan melalui sistematik reviu artikel terkait pelaksanaan Posbindu PTM yang dipublikasi secara online pada tahun 2015-2020. Artikel ditelusuri melalui mesin pencari google scholar, portal garuda, dan Pubmed/PMC dengan kata kunci: pelaksanaan Posbindu PTM, pemanfaatan Posbindu PTM, kendala dan peluang Posbindu PTM. Sebagai kriteria seleksi adalah artikel merupakan hasil penelitian atau evaluasi pelaksanaan Posbindu PTM dan pemanfaatannya, dapat menggunakan bahasa Indonesia maupun bahasa Inggris, dan artikel tersebut dapat diakses secara full text. Jumlah publikasi terkait berjumlah 44 artikel, dan 19 artikel memenuhi kriteria seleksi. Kegiatan Posbindu PTM umumnya belum dilaksanakan secara rutin dan komprehensif. Kegiatan dimanfaatkan oleh usia 35 tahun ke atas dan pasien PTM. Permasalahan pelaksanaan Posbindu PTM adalah Petugas kurang tepat dalam menetapkan sasaran, kurangnya dana operasional, dan keterbatasan kemampuan Kader melakukan konseling. Dukungan pemangku kepentingan merupakan peluang berkembangnya Posbindu PTM. Peningkatan manfaat Posbindu PTM memerlukan pembinaan petugas kesehatan, penguatan kompetensi kader dalam melakukan konseling/edukasi, dan penguatan regulasi di daerah. Kata kunci: Posbindu PTM; pelaksanaan; manfaat; kendala; peluang

1 January 2022 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
MSMarcel H.R. Sibarani
Marcel H.R. Sibarani
IWIka P. Wijaya
Ika P. Wijaya
ARAulia Rizka
Aulia Rizka
PSPradana Soewondo
Pradana Soewondo
WRWoro Riyadina
Woro Riyadina
DTDicky Levenus Tahapary
Dicky Levenus Tahapary

31 December 2020 in Media Penelitian dan Pengembangan Kesehatan
Verified
Journal Article
Open access
PDF file
WRWoro Riyadina
Woro Riyadina
EREkowati Rahajeng
Ekowati Rahajeng
SDSrilaning Driyah
Srilaning Driyah
One of the adverse effect of prolonged patients with diabetes mellitus (DM), coronary heart disease (CHD), and stroke was the emerge of chronic kidney disease (CKD) and it would be burden of the economic. The prognosis of CKD in new cases of DM, CHD, and stroke during followed up in Cohort Study Noncommunicable Disease Risk Factor in Bogor was not yet known. Aim to study was to obtain to CKD profile in DM, CHD, stroke, and comorbid incidences during Cohort Study Noncommunicable Disease Risk Factor. This article has been result of cross sectional further analysis of secondary data on 370 new cases of DM, CHD, and stroke that who were examined for blood creatinine levels and calculated eGFR on 2018 and 2019. DM was diagnosed from fasting glucose ≥126 mg/dl or post prandial glucose ≥200mg/dl. CHD was diagnosed by ECG examination and validated by cardiologist and stroke was diagnosed by anamnesis by a neurologist. The main variable is eGFR as an indicator of CKD which is the result of CKP-epi calculation based on creatinine levels in the blood. Other variables are age, sex, type of disease (DM, CHD, and stroke). Data were analyzed using chi-square test. The results showed that average age patients with CKD on new cases of DM, CHD, stroke, and comorbid in Bogor were 48.2 ± 8.6 years old. Proportions CKD on new cases of DM, CHD, strok and comorbid were 59.5%, 56.7%, 66.7% and 50.0%. CKD was higher in older woman than others. The prevalence of CKD was found very high in subjects with stroke, DM, CHD, and comorbid. So, it is necessary to prevent complications by early diagnosis of NCD with regular monitoring of kidney function by creatinine level test and avoid using drugs that caused kidney damage. Abstrak Salah satu komplikasi buruk dari penderita diabetes melitus (DM), penyakit jantung koroner (PJK), dan strok yang berkepanjangan adalah munculnya gangguan fungsi ginjal dan akan membebani ekonomi bagi penderitanya. Gambaran prognosis gangguan fungsi ginjal pada insiden DM, PJK, dan strok selama pemantauan Studi Kohor Faktor Risiko PTM (FRPTM) Bogor belum diketahui. Tujuan penelitian untuk mendapatkan gambaran gangguan fungsi ginjal pada kasus baru DM, PJK, dan strok yang muncul selama pemantauan Studi Kohor FRPTM. Artikel ini merupakan hasil analisis lanjut secara potong lintang dari data sekunder kasus baru (insiden) DM, PJK, dan strok pada Studi Kohor FRPTM sebanyak 370 subjek yang diperiksa kadar kreatinin darah dan dihitung eLFG pada tahun 2018 dan 2019. DM didiagnosis dari kadar gula darah puasa ≥126 mg/dl atau post prandial ≥200mg/dl. PJK dari hasil pemeriksaan EKG dan validasi dokter spesialis jantung dan strok hasil anamnesis oleh spesialis saraf dan sudah mengalami rawat jalan. Variabel utama adalah eLFG merupakan indikator terjadinya gangguan fungsi ginjal yang merupakan hasil hitung kadar kreatinin dalam darah dengan CKD-epi. Variabel lain adalah umur, jenis kelamin, jenis penyakit (DM, PJK, dan strok). Data dianalisis dengan uji chi-square. Hasil menunjukkan temuan gangguan fungsi ginjal pada penderita DM, PJK, strok, dan komorbid di Bogor berumur 48,2 ± 8,6 tahun dan proporsi masing-masing 59,5%, 56,7%, 66,7%, dan 50%. Subjek yang mengalami gangguan fungsi ginjal menunjukkan lebih banyak pada umur lebih tua dan perempuan. Tingginya proporsi gangguan fungsi ginjal pada penderita strok, DM, PJK, dan komorbid diperlukan pencegahan komplikasi sejak awal terdiagnosis PTM dengan memantau fungsi ginjal dengan pemeriksaan kadar kreatinin secara teratur, serta menghindari penggunaan obat yang menimbulkan kerusakan ginjal.

22 February 2020
Verified
Conference Paper
Open access
PDF file
EREkowati Rahajeng
Ekowati Rahajeng
ESEva Sulistiowati
Eva Sulistiowati
NKNunik Kusumawardhani
Nunik Kusumawardhani
The prevalence of obesity is high in Indonesia. It was associated with the increasing prevalence of diabetes (DM). Metabolic syndrome (MS) is known could increase DM prevalence. It is important to understand if the DM incidence is higher among those who have MS among obese. Objective: To determine DM risk obese among Indonesian adults with MS. Methods: Since 2011, Indonesia has conducted a prospective cohort study of NCD risk factors in Bogor City. Incident of DM during a median follow-up of 6 years was assessed among 5192 adults include 752 adults with MS. Diagnosis of DM determined by clinical examination and fasting blood glucose levels, i.e. ≥ 126 mg / dL and/or results of blood glucose 2 hours after glucose load, i.e. ≥ 200mg/dL. Consistency of high BMI was used to define obesity (≥30 kg/m2). MS was defined according to the criteria of the International Diabetes Federation (IDF). Results: The incidence rate of DM among adults with MS was 74 per 1,000 person-years. The incidence rate of DM among adult with MS and obese was 98 per 1,000 person-years. Meanwhile, among adult with MS but not obese was 25 per 1,000 person-years. In a multivariable model adjusted for age, sex, and family history of diabetes, a higher DM risk was observed among MS-obesecompared with MSnon obese (HR 3.64 [95% CI 2.36–5.66]. Therefore, DM risk obese among Indonesian adults with MS is high. Interventional programs are important to MS treatment and obese prevention including promoting awareness of healthy lifestyle changes.